EVH · Evolent Health, Inc Class A

NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD

Evolent Health Inc (EVH)

NEW YORK STOCK EXCHANGE, INC. Health Care
Move probability → Options chain →
$4.84 -0.04 (-0.72%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE $4.84
$4.78 $4.93
52-WEEK RANGE $4.84
$2.10 $8.30

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$546.1M
P/E (TTM1)—
EPS2 (TTM)$-4.52
Div Yield—
Beta31.03
Volume111,279
Open4.90
Prev Close4.88
Bid / Ask4.18 / 5.75
Next Earnings 2026-11-05 (after market close)

Analyst Recommendations

Strong buy 4 Buy 10 Hold 4 Sell 0 Strong sell 0

Aggregate ratings for 2026-10-01 (18 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
EVH +21.75%
vs S&P 500 +8.97%
1-YEAR RETURN
EVH -37.24%
vs S&P 500 -51.80%
6-MONTH RETURN
EVH +62.88%
3-MONTH RETURN
EVH -16.75%

Valuation Measures & Ratios

Enterprise Value4$1.39B
Forward P/E528.36
PEG Ratio6-0.01
Price / Sales (TTM1)0.26
Price / Book71.59
EV4 / Revenue0.66
EV4 / EBITDA21.42
Profit Margin-24.08%
Operating Margin-20.84%
Return on Equity (ROE8)-99.16%
Return on Assets (ROA9)-24.62%
Avg Volume (3M)2,818,010
Quarterly history (5 periods)
Measure Jun '26Mar '26Dec '25Sep '25Jun '25
Market cap $614.4M $253.0M $446.5M $734.2M $509.4M
P/E -1.22 -0.51 -0.84 -5.73 -3.90
Price/Sales 0.29 0.13 0.24 0.36 0.23
Price/Book 1.60 0.64 1.08 0.87 0.57
EV/Revenue 0.70 0.57 0.67 0.82 0.54
ROE -131.77% -125.26% -128.74% -15.22% -14.56%
ROA -25.61% -26.43% -28.14% -5.22% -5.30%

Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).

Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short12,906,700
Change from Prior Settlement-8.26%
% of Float—
Days to Cover (Short Ratio)5.47

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

  • Revenue growth is 46.9% on the provider's reported measure. Finnhub fundamentals ↗
  • Latest SEC filing is Form 4, filed 2026-08-28; review it for current changes and risks. SEC EDGAR ↗

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Revenue $652.5M $496.2M $468.7M $479.5M $444.3M $483.6M $646.5M $621.4M
Operating income -$9.6M -$10.6M — $886.0K -$1.2M -$1.6M — -$16.3M
Net income -$28.4M -$26.6M -$429.1M -$20.9M -$19.9M -$64.6M -$22.8M -$23.1M
EPS (diluted) $-0.25 $-0.24 $-3.84 $-0.24 $-0.44 $-0.63 $-0.27 $-0.27
EPS (basic) $-0.25 $-0.24 $-3.84 $-0.24 $-0.44 $-0.63 $-0.27 $-0.27
Operating margin -$1 -$2 — $0 -$0 -$0 — -$3

Balance sheet

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Total assets $1.97B $1.88B $1.90B $2.45B $2.46B $2.65B $2.54B $2.50B
Total liabilities $1.59B $1.48B $1.48B $1.61B $1.34B $1.52B $1.35B $1.28B
Stockholders' equity $383.2M $396.4M $415.2M $842.2M $896.0M $935.5M $1.00B $1.04B
Total current assets $610.5M $502.0M $506.4M $570.1M $562.3M $727.9M $607.1M $544.0M
Total current liabilities $492.8M $381.2M $385.3M $429.9M $557.5M $739.1M $715.5M $523.7M
Cash & equivalents $115.7M $142.0M $151.9M $116.7M $151.0M $246.5M $104.2M $96.6M

Cash flow

Line item Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24
Operating cash flow -$9.3M -$984.0K $48.8M $15.8M -$30.3M $4.6M -$26.2M $18.7M
Investing cash flow -$6.7M -$6.4M $82.2M -$8.8M -$60.5M -$13.1M -$19.9M -$19.7M
Financing cash flow -$11.0M -$4.0M -$93.0M -$41.8M -$8.9M $107.9M $96.9M -$9.0M
Capital expenditures — — — — — — — —
Depreciation & amortization $21.6M $21.6M $45.0M $23.6M $23.1M $24.1M $29.3M $29.7M
Share-based compensation $15.2M $10.6M $2.4M $14.7M $11.6M $11.1M -$6.1M $14.4M

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding EVH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Insider activity is not available for this symbol right now.

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-22 01:26 UTC

FiledFormReport periodOfficial filing
2026-08-2842026-08-26 View on SEC.gov →
2026-08-0610-Q2026-06-30 View on SEC.gov →
2026-08-068-K2026-08-06 View on SEC.gov →
2026-07-0642026-07-01 View on SEC.gov →
2026-07-0642026-07-01 View on SEC.gov →
2026-07-0642026-07-01 View on SEC.gov →
2026-07-0642026-07-01 View on SEC.gov →
2026-06-0842026-06-04 View on SEC.gov →
2026-06-0842026-06-04 View on SEC.gov →
2026-06-0842026-06-04 View on SEC.gov →
2026-06-0842026-06-04 View on SEC.gov →
2026-06-0842026-06-04 View on SEC.gov →

Headlines about EVH (Evolent Health, Inc Class A). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist